Regression Rates of CIN 2/CIN 3 in Women under 25 Years Old

被引：0
|
作者：
Bark, V [1 ]
Mondal, A. [1 ]
Hampl, M. [1 ]
机构：
[1] Klin Frauenheilkunde & Geburtshilfe, Dusseldorf, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718120
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P291
引用
收藏
页码：E184 / E184
页数：1
相关论文
共 50 条
  • [21] Review of colposcopic services and prevalence of CIN in the <25 years age group
    Raghavan, R.
    Saeed, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 285 - 285
  • [22] Prediction of cervical intraepithelial neoplasia grade 3 (CIN-3) regression
    Munk, Ane Cecilie
    Kruse, Arnold-Jan
    van Diermen, Bianca
    Janssen, Emiel A. M.
    Skaland, Ivar
    Baak, Jan P. A.
    APMIS, 2007, 115 (11) : 1312 - 1312
  • [23] Chromosome 3q26 gain for identification of women less likely to progress from LSIL/CIN 1 to HSIL/≥CIN 2
    Rodolakis, A.
    Biliatis, J.
    Thomakos, N.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S106 - S106
  • [24] Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study
    Godfrey, Michelle A. L.
    Nikolopoulos, Manolis
    Garner, Jessica E.
    Adib, Tania R.
    Mukhopadhyay, Debjani
    Rains, Jane S.
    Harper, Charlotte A.
    Wuntakal, Rekha
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 228 : 267 - 273
  • [25] THE CIN2 AND THE CIN3 INSERTION ELEMENTS OF ZEA-MAYS SSP PARVIGLUMIS
    VELSPALVE, JB
    SCHWARZSOMMER, Z
    SAEDLER, H
    PETERSON, PA
    MAYDICA, 1990, 35 (02): : 151 - 156
  • [26] Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus
    Gutierrez, CMC
    Tinoco, A
    Navarro, T
    Contreras, ML
    Cortes, RR
    Calzado, P
    Reyes, L
    Posternak, R
    Morosoli, G
    Verde, ML
    Rosales, R
    HUMAN GENE THERAPY, 2004, 15 (05) : 421 - 431
  • [27] THE ROLE OF THE VAGINAL MICROBIOTA IN THE REGRESSION OF UNTREATED CIN2 LESIONS
    Mitra, A.
    Macintyre, D.
    Ntritsos, G.
    Smith, A.
    Tsilidis, K.
    Marchesi, J.
    Bennett, P.
    Moscicki, A-B
    Kyrgiou, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A37 - A37
  • [28] Conservative management of cervical intraepithelial neoplasia (CIN2-3) in pregnant women
    Vlahos, G
    Rodolakis, A
    Diakomanolis, E
    Stefanidis, K
    Haidopoulos, D
    Abela, K
    Georgountzos, V
    Michalas, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2002, 54 (02) : 78 - 81
  • [29] Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years
    Sykes, Peter H.
    Simcock, Bryony J.
    Innes, Carrie R.
    Harker, Dianne
    Williman, Jonathan A.
    Whitehead, Martin
    van der Griend, Rachael A.
    Lawton, Beverley A.
    Hibma, Merilyn
    Fitzgerald, Peter
    Dudley, Narena M.
    Petrich, Simone
    Eva, Lois
    Bergzoll, Cecile
    Kathuria, Jyoti
    McPherson, Georgina
    Tristram, Amanda
    Faherty, Jim
    Hardie, Donna
    Robertson, Anne
    Robertson, Vicki
    Pather, Selvan
    Wrede, C. David
    Gastrell, Flora
    Fentiman, Gary
    John, Michael
    White, Elaine
    Parker, Catherine
    Sadler, Lynn
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 222.e1 - 222.e13
  • [30] What's the best treatment for CIN 2 or 3?
    Lozeau, Anne-Marie
    Schrager, Sarina
    Lowrie, Reed
    Huber, Timothy
    JOURNAL OF FAMILY PRACTICE, 2007, 56 (08): : 650 - 653
12345